| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.01B | +0.5% |
| R&D Expense | $150.0M | +2.7% |
| SG&A Expense | $3.34B | +1.3% |
| Operating Income | $8.63B | +7.6% |
| Interest Expense | $555.0M | +15.6% |
| Pre-tax Income | $8.57B | +7.3% |
| Income Tax | $2.00B | +10.4% |
| Net Income | $6.57B | +5.9% |
| EPS (Basic) | $13.71 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.85B | +4.0% |
| Accounts Receivable | $4.62B | -2.0% |
| Inventory | $1.95B | -8.0% |
| Current Assets | $12.95B | +2.6% |
| Total Assets | $80.15B | -0.8% |
| Current Liabilities | $14.54B | -7.5% |
| Long-term Debt | $17.40B | +18.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $9.42B | +1.3% |
| Capital Expenditures | $4.50B | +18.7% |
| Investing Cash Flow | -$4.64B | +0.6% |
| Financing Cash Flow | -$4.36B | +19.3% |
| Free Cash Flow | $4.93B | -10.7% |
| +8.0% |
| EPS (Diluted) | $13.62 | +8.2% |
| Total Liabilities |
| $40.66B |
| +2.4% |
| Stockholders' Equity | $38.09B | -4.1% |